Helicase-assisted continuous editing for programmable mutagenesis of endogenous genomes

Xi Dawn Chen,Zeyu Chen,George Wythes,Yifan Zhang,Benno C. Orr,Gary Sun,Ka Thao,Mounica Vallurupalli,Jing Sun,Mehdi Borji,Emre Tkacik,Haiqi Chen,Bradley E. Bernstein,Fei Chen
DOI: https://doi.org/10.1101/2024.02.01.577593
2024-02-01
Abstract:A major challenge in human genomics is to decipher the context specific relationship of sequence to function. However, existing tools for locus specific hypermutation and evolution in the native genome context are limited. Here we present a novel programmable platform for long-range, locus-specific hypermutation called helicase-assisted continuous editing (HACE). HACE leverages CRISPR-Cas9 to target a processive helicase-deaminase fusion that incurs mutations across large (>1000 bp) genomic intervals. We applied HACE to identify mutations in MEK1 that confer kinase inhibitor resistance, to dissect the impact of individual variants in SF3B1-dependent mis-splicing, and to evaluate noncoding variants in a stimulation-dependent immune enhancer of CD69. HACE provides a powerful tool for investigating coding and noncoding variants, uncovering combinatorial sequence-to-function relationships, and evolving new biological functions.
Genetics
What problem does this paper attempt to address?
The main problem this paper attempts to address is the development of a novel programmable genome editing technology, namely Helicase-Assisted Continuous Editing (HACE), for achieving high mutation rates at specific sites over long distances in endogenous mammalian genomes. This technology aims to overcome the limitations of existing genome editing tools in targeted mutation and evolution, particularly the ability to perform saturation mutagenesis in the context of endogenous genomes. Specifically, HACE utilizes the CRISPR-Cas9 system to localize a helicase-deaminase fusion protein to the target genomic region, thereby introducing multiple potentially interacting mutations within this region. This technology can continuously and potentially modulate mutation rates to explore the changes in the mutational landscape and adaptive landscape. In this way, HACE provides a versatile technical framework that can target genomic sites of interest individually or in combination, aiding in the deep understanding of the relationship between sequence and function and promoting the evolution of new biological functions. In the paper, the researchers demonstrate the functional characterization capabilities of HACE in both coding and non-coding regions, including identifying mutations that lead to MEK1 inhibitor resistance, analyzing individual variants affecting SF3B1-dependent mis-splicing, and evaluating non-coding variants in the CD69 stimulus-dependent immune enhancer. These applications demonstrate HACE as a powerful tool capable of performing saturation mutagenesis in both coding and non-coding regions, revealing how specific nucleotides influence genotype-phenotype associations and evolving new cellular functions.